Archive · 28 Jul 2025
Laurus Labs Share Price Climbs Following Strong Q1 Results
Laurus Labs, a pharmaceutical company, saw its stock price jump significantly due to excellent financial results.
Analysts have adjusted their predictions, with some recommending to buy the stock and others holding it steady.
The custom synthesis part of their business has been doing particularly well, which helped boost the company's overall success.
Laurus Labs' share price surged 8% to reach a record high.
The share price increase followed strong financial performance in the June quarter.
InCred Equities revised its target price to ₹850, maintaining a 'Hold' rating.
Choice Institutional Equities raised its target price to ₹1,025, with a 'Buy' rating.
The custom synthesis (CS) business saw substantial growth, up 130% YoY.
- Who
- Laurus Labs and financial analysts from InCred Equities and Choice Institutional Equities.
- What
- Laurus Labs' share price increased following strong Q1 results, leading to analyst upgrades.
- When
- The share price increase occurred on July 28, following the release of the company’s June quarter earnings.
- Where
- The trading occurred on the Indian stock market.
- Why
- Due to strong financial performance in the June quarter and positive growth in the custom synthesis business.
- Share Price Increase
- 8%
- New High
- ₹901 (intraday)
- InCred Equities Target Price
- ₹850
- Choice Equities Target Price
- ₹1,025
- CS Business Growth
- 130% YoY
